Akan Oton
Director/Board Member at Validus Pharmaceuticals LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Allen Ruiz | M | - |
Barings LLC (Private Equity)
 Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 6 years |
| Mike Freno | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | - |
| James R. Hunter | M | - |
Validus Pharmaceuticals LLC
 Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Validus Pharmaceuticals LLC develops and markets psychiatry and neurology products. The firm acquires and reformulates prescription products relevant to central nervous system diseases. The company was founded in 2007 and is headquartered in Parsippany, NJ. | - |
| Eric Lloyd | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 2 years |
| Mina Pacheco Nazemi | F | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 6 years |
| John Chiminski | M | 60 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 15 years |
| Joe Gorin | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 4 years |
| Séverine Maumy Laffineur | F | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | - |
| Rory Allan | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | - |
| Ralph Witt | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 12 years |
| Julie Niedzwiecki | F | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 8 years |
| Ben Pile | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 3 years |
| Caroline Mandeville | F | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 4 years |
| Steve Boehm | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | - |
| Rick Spencer | M | 61 |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 12 years |
| John Paul Ockerbloom | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 5 years |
| Lee Rios | M | - |
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Validus Pharmaceuticals LLC develops and markets psychiatry and neurology products. The firm acquires and reformulates prescription products relevant to central nervous system diseases. The company was founded in 2007 and is headquartered in Parsippany, NJ. | - |
| Chris Dowd | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 23 years |
| Ben W. Silver | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 16 years |
| Elizabeth Weindruch | F | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 9 years |
| Herbert W. Harris | M | - |
Validus Pharmaceuticals LLC
Validus Pharmaceuticals LLC Drugstore ChainsRetail Trade Validus Pharmaceuticals LLC develops and markets psychiatry and neurology products. The firm acquires and reformulates prescription products relevant to central nervous system diseases. The company was founded in 2007 and is headquartered in Parsippany, NJ. | - |
| Brant Schofield | M | - |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | 8 years |
| James Whittaker | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | - |
| Ram Sasisekharan | M | 58 |
Massachusetts Institute of Technology
| 28 years |
| Sheila E. Widnall | M | 85 |
Massachusetts Institute of Technology
| 26 years |
| Jack Stahl | M | 71 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 10 years |
| Naoki Ohta | M | - |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sam Khichi | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 years |
| Scott L. Houlton | M | 57 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | 7 years |
| Tom Finke | M | 60 |
Barings LLC (Private Equity)
Barings LLC (Private Equity) Investment ManagersFinance Barings LLC (Barings) is a private equity firm a subsidiary of Barings LLC founded in 1992. The firm is headquartered in Boston, Massachusetts. | 18 years |
| Hai Tao Cui | M | 49 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Maria Staton | F | 54 |
Massachusetts Institute of Technology
| 2 years |
| Netta Samroengraja | F | - |
The Wharton School of the University of Pennsylvania
The Trustees of Columbia University in The City of New York
| 7 years |
| Kareem Akhtar | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jamie Flinchbaugh | M | - |
Massachusetts Institute of Technology
| 2 years |
| Chris Turner | M | - |
Massachusetts Institute of Technology
| 6 years |
| Jane F. Golden | F | - |
The Trustees of Columbia University in The City of New York
| 1 years |
| Andy Wheeler | M | 45 |
Massachusetts Institute of Technology
| 5 years |
| Seth T. Goldsamt | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Celine Fung | F | - |
Massachusetts Institute of Technology
| 2 years |
| Earl Jones | M | - |
Massachusetts Institute of Technology
| 3 years |
| Daniel Abel Monteiro Palhares Traça | M | 57 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Nadav Besner | M | 44 |
The Wharton School of the University of Pennsylvania
| 5 years |
| David Carter | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Muhammad Mohsin Al-Saggaf | M | 56 |
Massachusetts Institute of Technology
| 5 years |
| Vishal Kapur | M | - |
Massachusetts Institute of Technology
| 5 years |
| Errol Arkilic | M | - |
Massachusetts Institute of Technology
| 6 years |
| Ko Yukawa | M | 58 |
The Trustees of Columbia University in The City of New York
| 2 years |
| Juan R Pita | M | - |
The Wharton School of the University of Pennsylvania
| 11 years |
| David Quiram | M | 49 |
Massachusetts Institute of Technology
| 5 years |
| Tian Hang Hu | M | 46 |
Massachusetts Institute of Technology
| 5 years |
| Melissa Gordon | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Yi Han Fang | F | 51 |
The Trustees of Columbia University in The City of New York
| 3 years |
| Jamie Kramer | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Susan Y. Choe | F | - |
The Trustees of Columbia University in The City of New York
| 2 years |
| Kurt R. Nielsen | M | 56 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Neil Renninger | M | 49 |
Massachusetts Institute of Technology
| 5 years |
| Peter Rice | M | - |
Massachusetts Institute of Technology
| 6 years |
| William Feehery | M | 54 |
Massachusetts Institute of Technology
| 5 years |
| Fauzia Rashid | F | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Celia Huey | F | - |
Massachusetts Institute of Technology
The Wharton School of the University of Pennsylvania
| 8 years |
| Jake Seid | M | - |
Massachusetts Institute of Technology
| 2 years |
| Matthias B. Jaffé | M | 50 |
Massachusetts Institute of Technology
| 3 years |
| Charles W. Silvey | M | 65 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | - |
| Gene Yoon | M | 49 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Adrianna Ma | F | 50 |
Massachusetts Institute of Technology
| 5 years |
| Neal Rosenberg | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Morten Westye Høegh | M | 51 |
Massachusetts Institute of Technology
| 4 years |
| Stefan Auerbach | M | 61 |
Massachusetts Institute of Technology
| 1 years |
| Erik Herzfeld | M | 50 |
Massachusetts Institute of Technology
| 2 years |
| Taras Ivanenko | M | - |
Massachusetts Institute of Technology
| 5 years |
| Pilar Gomez-Bravo | F | - |
Massachusetts Institute of Technology
| 2 years |
| Brian G. R. Hughes | M | - |
Massachusetts Institute of Technology
| 4 years |
| Liliana Castillo Dearth | F | 55 |
Massachusetts Institute of Technology
| 2 years |
| Anita Killian | F | - |
Massachusetts Institute of Technology
| 10 years |
| Obadiah J. Plante | M | - |
Massachusetts Institute of Technology
| 3 years |
| Robert McIntyre | M | - |
Massachusetts Institute of Technology
| 4 years |
| Erik M. Glover | M | - |
Massachusetts Institute of Technology
| 4 years |
| Bernd Schoner | M | - |
Massachusetts Institute of Technology
| 3 years |
| Kin Yee Pong | M | 47 |
Massachusetts Institute of Technology
| 4 years |
| Mark MaClean | M | - |
Massachusetts Institute of Technology
| 1 years |
| Anders Wilhjelm | M | 58 |
Massachusetts Institute of Technology
| 2 years |
| Sudhir Borgonha | M | - |
Massachusetts Institute of Technology
| 4 years |
| Shane M. Farritor | M | - |
Massachusetts Institute of Technology
| 3 years |
| James L. McGrath | M | - |
Massachusetts Institute of Technology
| 3 years |
| Jody L. House | M | - |
Massachusetts Institute of Technology
| 3 years |
| Geoff Bloss | M | - |
Massachusetts Institute of Technology
| 2 years |
| Zeeshan Mirza | M | - |
Massachusetts Institute of Technology
| 2 years |
| Michael A. Klug | M | - |
Massachusetts Institute of Technology
| 6 years |
| Gian Felice | M | 51 |
Massachusetts Institute of Technology
| 4 years |
| Steve M. Reid | M | - |
Massachusetts Institute of Technology
| 3 years |
| Jeffrey Hung | M | - |
Massachusetts Institute of Technology
| 4 years |
| Geeta Sachdev | F | - |
Massachusetts Institute of Technology
| 2 years |
| Joseph Bishop | M | - |
Massachusetts Institute of Technology
| 4 years |
| Sonny Vu | M | - |
Massachusetts Institute of Technology
| 4 years |
| Christine Joann Jantz | F | 67 |
Massachusetts Institute of Technology
| 2 years |
| Jascha Franklin-Hodge | M | - |
Massachusetts Institute of Technology
| 1 years |
| Marin Soljacic | M | - |
Massachusetts Institute of Technology
| 4 years |
| Ann DeWitt | M | - |
Massachusetts Institute of Technology
| 3 years |
| Tao Ye | M | 57 |
Massachusetts Institute of Technology
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Akan Oton
- Personal Network
